Bionow | News

Report: Preparation, Characterisation and in vitro Assessment of siRNA-loaded Li...

Oct 30th 2024

Medicines Discovery Catapult is developing new ways to characterise the physical properties of nanoparticles using single-molecule localisation microscopy.

Tech Pioneer Awarded to Manchester Entrepreneur

Jul 5th 2024

Dr. Farid Khan, CEO of PharmaKure was awarded Asian Tech Pioneer in his work in Biotech.

Five Years of Reshaping Drug Discovery

May 2nd 2023

Medicines Discovery Catapult Marks Milestone Anniversary

Sustaining Skills to Supercharge the UK Life Sciences Sector

Mar 16th 2023

Medicines Discovery Catapult Celebrates British Science Week 2023

Medicines Discovery Catapult Appoints International Entrepreneur to Bolster Comm...

Oct 26th 2022

New appointment reflects ambition for growth to drive drug discovery innovation

SHORTLIST ANNOUNCED FOR INAUGURAL SUSTAINABLE MEDICINES PACKAGING AWARDS

Aug 30th 2022

Finalists showcase innovations in sustainable pharmaceutical packaging, with winners to be announced at Connect in Pharma

Medicines Discovery Catapult and ZEISS Set Sights on Advancing Microscopy

Aug 11th 2022

Medicines Discovery Catapult (MDC) and ZEISS have joined forces to improve drug discovery and early development of complex medicines by harnessing the power of advanced microscopy solutions.

New report finds personalised testing of common medicines must be offered throug...

Mar 30th 2022

The report was produced by a working party chaired by a University of Liverpool academic, Professor Sir Munir Pirmohamed

The UK'S new medicines and medical devices regime- next steps

Mar 11th 2021

The Medicines and Medical Devices Act has now become law. Much of the legislation simply sets up powers and frameworks for development of the UK’s regulatory system for medicines, veterina...

Biology 2.0: Combining machine-learning, robotics and biology to deliver drug di...

Dec 21st 2020

Intelligent OMICS, Arctoris and Medicines Discovery Catapult test in silico pipeline for identifying new molecules for cancer treatment

UK Innovators Target Nanoparticles at Inoperable Cancers

Dec 21st 2020

Active Needle Technology, Xerion Healthcare and Medicines Discovery Catapult win funding to begin ground-breaking project

Boost for Mental Health Medicines R&D as COMPASS Pathways Joins the Psychiatry C...

Nov 9th 2020

Global mental health care company, COMPASS Pathways plc has joined the Psychiatry Consortium, bringing additional expertise and insights to the group.

News